Arild Mæland

     

    Publications 2016

    Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O (2016)
    Hepatitis C reinfection after sustained virological response
    J Hepatol, 64 (5), 1020-1026
    DOI 10.1016/j.jhep.2016.01.001, PubMed 26780289

    Publications 2014

    Maeland A (2014)
    Antiretroviral treatment initiation
    Lancet Infect Dis, 14 (12), 1175
    DOI 10.1016/S1473-3099(14)70947-8, PubMed 25455976

    Publications 2013

    Ushakova A, Pettersen FO, Mæland A, Lindqvist BH, Kvale D (2013)
    Bayesian estimation of HIV-1 dynamics in vivo
    Math Med Biol, 32 (1), 38-55
    DOI 10.1093/imammb/dqt018, PubMed 24078026

    Publications 2010

    Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
    [Syphilis and blood transfusion]
    Tidsskr Nor Laegeforen, 130 (8), 839-41
    DOI 10.4045/tidsskr.08.0188, PubMed 20418930

    Publications 2009

    Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
    Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
    J Clin Microbiol, 47 (7), 2170-4
    DOI 10.1128/JCM.00519-09, PubMed 19420166

    Publications 2007

    Jensenius M, Maeland A, Brubakk O (2007)
    Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics
    Travel Med Infect Dis, 6 (1-2), 45-7
    DOI 10.1016/j.tmaid.2007.09.043, PubMed 18342274

    Publications 2006

    Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V (2006)
    [HIV/AIDS--from lethal syndrome to chronic disease]
    Tidsskr Nor Laegeforen, 126 (23), 3121-4
    PubMed 17160119

    Skeie L, Maeland A (2006)
    Can efavirenz be taken in the morning?
    Scand J Infect Dis, 38 (11-12), 1089-91
    DOI 10.1080/00365540600794386, PubMed 17148083

    Publications 2003

    Maeland A, Ronnestad I, Waagbo R (2003)
    Folate in eggs and developing larvae of Atlantic halibut, Hippoglossus hippoglossus L.
    Aquac. Nutr., 9 (3), 185-188

    Publications 2002

    Bjøro K, Bell H, Hellum KB, Skaug K, Raknerud N, Sandvei P, Døskeland B, Maeland A, Lund-Tønnesen S, Myrvang B (2002)
    Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study
    Scand J Gastroenterol, 37 (2), 226-32
    DOI 10.1080/003655202753416920, PubMed 11843062

    Bruun JN, Maeland A (2002)
    [Mother-to-child transmission of HIV]
    Tidsskr Nor Laegeforen, 122 (11), 1143; author reply 1143
    PubMed 12043061

    Publications 2001

    Ormaasen V, Maeland A (2001)
    [Tuberculosis among HIV-infected persons in Norway]
    Tidsskr Nor Laegeforen, 121 (29), 3425-30
    PubMed 11826791

    Publications 2000

    Maeland A, Ronnestad I, Fyhn HJ, Berg L, Waagbo R (2000)
    Water-soluble vitamins in natural plankton (copepods) during two consecutive spring blooms compared to vitamins in Artemia franciscana nauplii and metanauplii
    Mar. Biol., 136 (5), 765-772

    Olsen AI, Maeland A, Waagbo R, Olsen Y (2000)
    Effect of algal addition on stability of fatty acids and some water-soluble vitamins in juvenile Artemia franciscana
    Aquac. Nutr., 6 (4), 263-273

    Publications 1999

    Bell H, Hellum K, Harthug S, Myrvang B, Ritland S, Maeland A, von der Lippe B, Bjøro K, Skaug K, Gutigard BG, Raknerud N, Simmonds P (1999)
    Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group
    Scand J Gastroenterol, 34 (2), 194-8
    PubMed 10192200

    Maeland A, Rosenlund G, Stoss J, Waagbo R (1999)
    Weaning of Atlantic halibut Hippoglossus hippoglossus L. using formulated diets with various levels of ascorbic acid
    Aquac. Nutr., 5 (3), 211-219

    Maeland A, Sandnes K (1999)
    Determination of biotin in low-temperature fish-meal processed from different species by means of a microbiological method using Lactobacillus plantarum as test organism
    J. Sci. Food Agric., 79 (10), 1298-1300

    Publications 1998

    Brantsaeter AB, Hoel T, Kristianslund TI, Maeland A (1998)
    [Tularemia after tick bite in Vestfold]
    Tidsskr Nor Laegeforen, 118 (8), 1191-3
    PubMed 9567695

    Jarvis LM, Bell H, Simmonds P, Hawkins A, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K (1998)
    The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group
    Scand J Gastroenterol, 33 (2), 195-200
    PubMed 9517532

    Maeland A, Waagbo R (1998)
    Examination of the qualitative ability of some cold water marine teleosts to synthesise ascorbic acid
    Comp. Biochem. Physiol. A-Mol. Integr. Physiol., 121 (3), 249-255

    Maeland A, Waagbo R, Sandnes K, Hjeltnes B (1998)
    Biotin in practical fish-meal based diet for Atlantic salmon Salmo salar L. fry
    Aquac. Nutr., 4 (4), 241-247

    Publications 1997

    Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Gutigard BG, Skjaerven R, Prescott LE, Simmonds P (1997)
    Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group
    Scand J Infect Dis, 29 (1), 17-22
    DOI 10.3109/00365549709008658, PubMed 9112292

    Jensenius M, Maeland A, Kvale D, Farstad IN, Vene S, Bruu AL (1997)
    [Q-fever imported into Norway]
    Tidsskr Nor Laegeforen, 117 (27), 3937-40
    PubMed 9441420

    Jensenius M, Maeland A, Vene S (1997)
    [Endemic typhus imported to Norway]
    Tidsskr Nor Laegeforen, 117 (17), 2447-9
    PubMed 9265302

    Maeland A (1997)
    [Screening of pregnant women for toxoplasma infection]
    Tidsskr Nor Laegeforen, 117 (8), 1184-5
    PubMed 9148496

    Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
    Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
    Scand J Gastroenterol, 32 (12), 1256-60
    DOI 10.3109/00365529709028156, PubMed 9438325

    Publications 1996

    Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Prescott L, Simmonds P (1996)
    Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group
    Scand J Infect Dis, 28 (4), 357-9
    DOI 10.3109/00365549609037919, PubMed 8893398

    Schrumpf E, Bjøro K, Bell H, Harthug S, Hellum KB, Myrvang B, Maeland A, Ritland S (1996)
    [Treatment of hepatitis C]
    Tidsskr Nor Laegeforen, 116 (15), 1792-4
    PubMed 8693463

    Publications 1995

    BJORO K, KRARUP H, BELL H, CHRISTOPHERSEN P, EVENSEN S, FROLAND SS, LAURSEN A, VANDERLIPPE B, MAELAND A, RANEK L, RINGLARSEN H, SCHOU G, SCHRUMPF E, TYGSTRUP N (1995)
    2 DOSE REGIMENS OF RECOMBINANT INTERFERON-ALPHA-2B IN CHRONIC HEPATITIS-C VIRUS-INFECTION - BIOCHEMISTRY, HEPATITIS-C VIRUS RNA, AND LIVER HISTOLOGY AS RESPONSE INDICES
    Scand. J. Gastroenterol., 30 (11), 1119-1124

    Bjøro K, Krarup H, Bell H, Christophersen P, Evensen S, Frøland SS, Laursen A, B vd Lippe B, Maeland A, Ranek L (1995)
    Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices
    Scand J Gastroenterol, 30 (11), 1119-24
    PubMed 8578174

    Publications 1993

    Sandven P, Bjørneklett A, Maeland A (1993)
    Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group
    Antimicrob Agents Chemother, 37 (11), 2443-8
    DOI 10.1128/AAC.37.11.2443, PubMed 8285631

    Publications 1992

    Larsen J, Skaug K, Maeland A (1992)
    Second-generation anti-HCV tests predict infectivity
    Vox Sang, 63 (1), 39-42
    PubMed 1384236

    LARSEN J, SKAUG K, MAELAND A (1992)
    2ND-GENERATION ANTI-HCV TESTS PREDICT INFECTIVITY
    Vox Sang., 63 (1), 39-42

    NORRBY SR, GOTZSCHE PC, MELANDER H, ANDERSEN P, LAHDEVIRTA J, GUDMUNDSSON S, BRUUN JN, BERGLUND O, SKINHOJ P, GERSTOFT J, THYBO S, GIEMSING P, SOEBERG B, ISAGER H, MOLLER A, KROON S, MAELAND A, DOBLOUG JH, FROLAND S, SCHREINER A, HELLUM KB, LINDBACK S, JACOBSSON B, PEHRSON PO, SKOLDENBERG B et al. (1992)
    DOUBLE-BLIND DOSE-RESPONSE STUDY OF ZIDOVUDINE IN AIDS AND ADVANCED HIV-INFECTION
    Br. Med. J., 304 (6818), 13-17

    Publications 1991

    Larsen J, Hetland G, Skaug K, Maeland A (1991)
    [Viral hepatitis and blood transfusion]
    Tidsskr Nor Laegeforen, 111 (7), 825-8
    PubMed 1850559

    Larsen J, Skaug K, Maeland A, Hetland G, Stoervold G (1991)
    Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis
    Transfus Med, 1 (1), 13-6
    PubMed 9259821

    MAELAND A (1991)
    SYSTEMIC CANDIDA INFECTIONS
    Curr. Med. Res. Opin., 12 1, 26-31

    Maeland A (1991)
    [Cutaneous leishmaniasis]
    Tidsskr Nor Laegeforen, 111 (29), 3512-4
    PubMed 1796438

    Publications 1989

    MAELAND A, SKAUG K, STORVOLD G, KITTELSEN P (1989)
    REACTIVATION OF HEPATITIS-B
    Lancet, 1 (8646), 1083

    Publications 1988

    Maeland A (1988)
    [Acute HIV disease]
    Tidsskr Nor Laegeforen, 108 (22), 1619-20, 1654
    PubMed 3413748

    Page visits: 1848